Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Peritoneal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27Cisplatin 17Oxaliplatin 16Cytoreduction Surgical Procedures 15Paclitaxel 12Fluorouracil 10Mitomycin 8Leucovorin 8Doxorubicin 7Docetaxel 5Neoadjuvant Therapy 4Blood Specimen Collection 4Taxes 3Surgical Procedures, Operative 3Chemotherapy, Adjuvant 3Carboplatin 3Bevacizumab 3catumaxomab 2Platinum 2Palliative Care 2Observation 2Nivolumab 2Mitozytrex 2Laparoscopy 2Interviews as Topic 2Indocyanine Green 2Folfox protocol 2Albumin-Bound Paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peritoneal Neoplasms × abagovomab × Clear all
NCT00103545 2006-10-02

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

AGO Study Group

Phase 1/2 Completed
36 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡